title: Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivatives.
abstract: The phosphoinositide 3-kinase (PI3K) family catalyzes the ATP-dependent phosphorylation of the 3'-hydroxyl group of phosphatidylinositols and plays an important role in cell growth and survival. There is abundant evidence demonstrating that PI3K signaling is dysregulated in many human cancers, suggesting that therapeutics targeting the PI3K pathway may have utility for the treatment of cancer. Our efforts to identify potent, efficacious, and orally available PI3K/mammalian target of rapamycin (mTOR) dual inhibitors resulted in the discovery of a series of substituted quinolines and quinoxalines derivatives. In this report, we describe the structure-activity relationships, selectivity, and pharmacokinetic data of this series and illustrate the in vivo pharmacodynamic and efficacy data for a representative compound.
authors: Department of Chemistry Research and Discovery, Amgen Inc., Thousand Oaks, California 91320-1799, United States. nobukon@amgen.com
authors: Nobuko
authors: N
authors: Nishimura
authors: Aaron
authors: A
authors: Siegmund
authors: Longbin
authors: L
authors: Liu
authors: Kevin
authors: K
authors: Yang
authors: Marian C
authors: MC
authors: Bryan
authors: Kristin L
authors: KL
authors: Andrews
authors: Yunxin
authors: Y
authors: Bo
authors: Shon K
authors: SK
authors: Booker
authors: Sean
authors: S
authors: Caenepeel
authors: Daniel
authors: D
authors: Freeman
authors: Hongyu
authors: H
authors: Liao
authors: John
authors: J
authors: McCarter
authors: Erin L
authors: EL
authors: Mullady
authors: Tisha
authors: T
authors: San Miguel
authors: Raju
authors: R
authors: Subramanian
authors: Nuria
authors: N
authors: Tamayo
authors: Ling
authors: L
authors: Wang
authors: Douglas A
authors: DA
authors: Whittington
authors: Leeanne
authors: L
authors: Zalameda
authors: Nancy
authors: N
authors: Zhang
authors: Paul E
authors: PE
authors: Hughes
authors: Mark H
authors: MH
authors: Norman